Skip to content

Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques

A 1-year Prospective, Multicenter, Non-Randomized, Observational, Study to Evaluate Optimal Improvement of Vein Graft Patency Long Term by the Implementation of Novel Endoscopic Harvesting Techniques

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01697176
Acronym
OPTION
Enrollment
100
Registered
2012-10-02
Start date
2010-08-31
Completion date
2014-08-31
Last updated
2014-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

This is an observational study of lone Coronary Artery Bypass Grafting procedures with endoscopic vein graft harvesting using best harvesting practices.

Detailed description

This is a prospective, multi-center, non-randomized, observational study of 100 patients who will undergo routine coronary artery bypass grafting. Eligible candidates will undergo lone Coronary Artery Bypass Graft (CABG) procedures with endoscopic vein harvesting using best harvesting practices, defined as: systemic heparinization prior to vein manipulation, standardization of vein graft harvesting techniques, pressure limiting syringe and 3 month use of dual anti-platelet therapy. Patients will undergo a CT angiography at 30 days and 12 months to assess vein graft patency.

Interventions

None listed

Sponsors

Maquet Cardiovascular
CollaboratorINDUSTRY
Cardiopulmonary Research Science and Technology Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age greater than 18 and able to provide consent * Eligible for endoscopic vein harvesting * Minimum of two non sequential vein grafts * Willing to comply with requirements of protocol

Exclusion criteria

* Previous CABG * Previous or concomitant valve surgery * Any other concomitant cardiac procedure other than surgical ablation or incidental PFO repair * Intolerance to Iodine or IV contrast that cannot be controlled with pre-medication * Renal insufficiency with GFR measurement ≤ 40, unless dialysis dependent * Abnormal platelet level defined as Plt Count \>400,000 * Abnormal platelet function (hypercoagulable state) as evidenced by TEG testing * Allergy to or presence of a condition that the investigator feels may prevent safe administration of ASA or Plavix post-operatively. * Patient has a co-morbid condition that in the opinion of the investigator poses undue risk for successful endovascular harvesting of the vein

Design outcomes

Primary

MeasureTime frameDescription
Optimal Improvement of Vein Graft Patency Long Term by the Implementation of Novel Endoscopic Harvesting Techniques12 monthsTo demonstrate improved vein graft patency rates at 12 months for endoscopically harvest saphenous vein grafts by employment of modifications to existing techniques in vein graft handling during harvests. Vein graft patency will be measured at 30 days post CABG and at one year post CABG as evaluated by cardiac CT angiography or cardiac catheterization.

Secondary

MeasureTime frameDescription
OPTION12 monthsTo develop a standardized approach for harvesting, handling and preparing vein grafts in the endoscopic approach. By capturing the following: 1. Incidence of vein graft failure at the time of initial CABG as evaluated by transit time graft flow measurements 2. Incidence of vein graft failure at post-operative day 30 as evaluated by cardiac CT angiography or cardiac catheterization 3. Incidence of vein graft failure at each interval (30 day and 12 month) as categorized by: 1. Harvested vessel 2. vein graft destinations 3. vein graft quality

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026